Market closed
InspireMD/$NSPR
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About InspireMD
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.
Ticker
$NSPR
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Tel Aviv, Israel
Employees
80
Website
InspireMD Metrics
BasicAdvanced
$82M
Market cap
-
P/E ratio
-$0.74
EPS
0.93
Beta
-
Dividend rate
Price and volume
Market cap
$82M
Beta
0.93
52-week high
$3.42
52-week low
$1.81
Average daily volume
67K
Financial strength
Current ratio
6.386
Quick ratio
5.874
Long term debt to equity
1.649
Total debt to equity
1.649
Management effectiveness
Return on assets (TTM)
-37.24%
Return on equity (TTM)
-66.75%
Valuation
Price to revenue (TTM)
17.422
Price to book
1.95
Price to tangible book (TTM)
1.95
Price to free cash flow (TTM)
-5.768
Growth
Revenue change (TTM)
24.70%
Earnings per share change (TTM)
-31.36%
3-year revenue growth (CAGR)
27.73%
3-year earnings per share growth (CAGR)
-32.62%
What the Analysts think about InspireMD
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for InspireMD stock.
InspireMD Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
InspireMD Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
InspireMD News
AllArticlesVideos
InspireMD Announces First Patient Enrolled in the CGUARDIANS II Pivotal Study of the CGuard Prime Carotid Stent System in Transcarotid Artery Revascularization Procedures (TCAR)
GlobeNewsWire·2 days ago
InspireMD Announces Appointment of Accomplished Medical Technology Executive Scott R. Ward to its Board of Directors
GlobeNewsWire·2 weeks ago
InspireMD, Inc. (NSPR) Q3 2024 Earnings Call Transcript
Seeking Alpha·4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for InspireMD stock?
InspireMD (NSPR) has a market cap of $82M as of December 11, 2024.
What is the P/E ratio for InspireMD stock?
The price to earnings (P/E) ratio for InspireMD (NSPR) stock is 0 as of December 11, 2024.
Does InspireMD stock pay dividends?
No, InspireMD (NSPR) stock does not pay dividends to its shareholders as of December 11, 2024.
When is the next InspireMD dividend payment date?
InspireMD (NSPR) stock does not pay dividends to its shareholders.
What is the beta indicator for InspireMD?
InspireMD (NSPR) has a beta rating of 0.93. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.